127 related articles for article (PubMed ID: 12732338)
1. Plasma orexin-A-like immunoreactivity in patients with sleep apnea hypopnea syndrome.
Nishijima T; Sakurai S; Arihara Z; Takahashi K
Peptides; 2003 Mar; 24(3):407-11. PubMed ID: 12732338
[TBL] [Abstract][Full Text] [Related]
2. Low plasma orexin-A levels were improved by continuous positive airway pressure treatment in patients with severe obstructive sleep apnea-hypopnea syndrome.
Sakurai S; Nishijima T; Takahashi S; Yamauchi K; Arihara Z; Takahashi K
Chest; 2005 Mar; 127(3):731-7. PubMed ID: 15764751
[TBL] [Abstract][Full Text] [Related]
3. Plasma orexin-A levels in obstructive sleep apnea-hypopnea syndrome.
Igarashi N; Tatsumi K; Nakamura A; Sakao S; Takiguchi Y; Nishikawa T; Kuriyama T
Chest; 2003 Oct; 124(4):1381-5. PubMed ID: 14555569
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of daytime plasma orexin-A-like immunoreactivity concentrations in patients with obstructive sleep apnea hypopnea syndrome.
Sakurai S; Nishijima T; Takahashi S; Yamauchi K; Arihara Z; Takahashi K
Respiration; 2004; 71(4):380-4. PubMed ID: 15316212
[TBL] [Abstract][Full Text] [Related]
5. Plasma orexin-A levels in obstructive sleep apnea-hypopnea syndrome.
Sakurai S; Nishijima T; Arihara Z; Takahashi K
Chest; 2004 May; 125(5):1963; author reply 1963-4. PubMed ID: 15136419
[No Abstract] [Full Text] [Related]
6. [Diagnostic values of serum orexin-A levels in children with obstructive sleep apnea-hypopnea syndrome].
Abulaiti A; Xu PR; Duo LK
Zhonghua Er Ke Za Zhi; 2008 Apr; 46(4):291-6. PubMed ID: 19099733
[TBL] [Abstract][Full Text] [Related]
7. Immunoreactive orexin-A in human plasma.
Arihara Z; Takahashi K; Murakami O; Totsune K; Sone M; Satoh F; Ito S; Mouri T
Peptides; 2001 Jan; 22(1):139-42. PubMed ID: 11179609
[TBL] [Abstract][Full Text] [Related]
8. Plasma orexin-A is lower in patients with narcolepsy.
Higuchi S; Usui A; Murasaki M; Matsushita S; Nishioka N; Yoshino A; Matsui T; Muraoka H; Ishizuka Y; Kanba S; Sakurai T
Neurosci Lett; 2002 Jan; 318(2):61-4. PubMed ID: 11796186
[TBL] [Abstract][Full Text] [Related]
9. Orexin-A and leptin change inversely in fasting non-obese subjects.
Komaki G; Matsumoto Y; Nishikata H; Kawai K; Nozaki T; Takii M; Sogawa H; Kubo C
Eur J Endocrinol; 2001 Jun; 144(6):645-51. PubMed ID: 11375799
[TBL] [Abstract][Full Text] [Related]
10. Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients.
Dalal MA; Schuld A; Haack M; Uhr M; Geisler P; Eisensehr I; Noachtar S; Pollmächer T
Neurology; 2001 Jun; 56(12):1749-51. PubMed ID: 11425946
[TBL] [Abstract][Full Text] [Related]
11. [The changes and implications of plasma orexin-A levels in patients with obstructive sleep apnea-hypopnea syndrome].
Liao XM; Yu Q
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jun; 28(6):368-71. PubMed ID: 16008971
[TBL] [Abstract][Full Text] [Related]
12. Orexin A immunoreactivity and preproorexin mRNA in the brain of Zucker and WKY rats.
Taheri S; Gardiner J; Hafizi S; Murphy K; Dakin C; Seal L; Small C; Ghatei M; Bloom S
Neuroreport; 2001 Mar; 12(3):459-64. PubMed ID: 11234746
[TBL] [Abstract][Full Text] [Related]
13. Decreased plasma levels of orexin-A in sleep apnea.
Busquets X; Barbé F; Barceló A; de la Peña M; Sigritz N; Mayoralas LR; Ladaria A; Agustí A
Respiration; 2004; 71(6):575-9. PubMed ID: 15627867
[TBL] [Abstract][Full Text] [Related]
14. Hypothalamic orexins/hypocretins as regulators of breathing.
Williams RH; Burdakov D
Expert Rev Mol Med; 2008 Oct; 10():e28. PubMed ID: 18828950
[TBL] [Abstract][Full Text] [Related]
15. Functional roles of orexin in obstructive sleep apnea: From clinical observation to mechanistic insights.
Sithirungson S; Sonsuwan N; Chattipakorn SC; Chattipakorn N; Shinlapawittayatorn K
Sleep Med; 2023 Jan; 101():40-49. PubMed ID: 36334500
[TBL] [Abstract][Full Text] [Related]
16. [Plasma orexin-A level in patients with obstructive apnea-hypopnea syndrome].
Yao X; Yang H; Zhang G; Tang Y
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Jun; 20(12):547-9. PubMed ID: 16941964
[TBL] [Abstract][Full Text] [Related]
17. Plasma orexin concentrations in patients on hemodialysis.
Sugimoto T; Nagake Y; Sugimoto S; Akagi S; Ichikawa H; Nakamura Y; Ogawa N; Makino H
Nephron; 2002 Apr; 90(4):379-83. PubMed ID: 11961395
[TBL] [Abstract][Full Text] [Related]
18. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.
Mignot E; Lammers GJ; Ripley B; Okun M; Nevsimalova S; Overeem S; Vankova J; Black J; Harsh J; Bassetti C; Schrader H; Nishino S
Arch Neurol; 2002 Oct; 59(10):1553-62. PubMed ID: 12374492
[TBL] [Abstract][Full Text] [Related]
19. Reduced orexin-A levels in frontotemporal dementia: possible association with sleep disturbance.
Çoban A; Bilgiç B; Lohmann E; Küçükali Cİ; Benbir G; Karadeniz D; Hanagasi HA; Tüzün E; Gürvit H
Am J Alzheimers Dis Other Demen; 2013 Sep; 28(6):606-11. PubMed ID: 23813609
[TBL] [Abstract][Full Text] [Related]
20. Characterization of sleep-wake patterns in a novel transgenic mouse line overexpressing human prepro-orexin/hypocretin.
Mäkelä KA; Wigren HK; Zant JC; Sakurai T; Alhonen L; Kostin A; Porkka-Heiskanen T; Herzig KH
Acta Physiol (Oxf); 2010 Mar; 198(3):237-49. PubMed ID: 20003098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
